Skip to main content
Equibles

Jonathan L. Schechter

Board Member

PharmaCyte Biotech, Inc. (PMCB)

Board Member

TAO Synergies Inc. (TAOX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jonathan L. Schechter

Jonathan L. Schechter is recorded as Board Member at PharmaCyte Biotech, Inc. (PMCB) and Board Member at TAO Synergies Inc. (TAOX). PharmaCyte Biotech, Inc. reported in an 8-K filed April 2, 2026 that Jonathan L. Schechter was appointed Director, effective March 30, 2026. TAO Synergies Inc. reported in an 8-K filed August 29, 2025 that Jonathan L. Schechter resigned as member of the board of directors, effective August 28, 2025. TAO Synergies Inc. reported in an 8-K filed October 13, 2022 that Jonathan L. Schechter was appointed Director, effective October 11, 2022. Equibles holds 5 filed executive changes naming Jonathan L. Schechter; each is listed under recent activity with its source filing.

“The election of five directors, each to hold office until the annual meeting of stockholders for the year ended April 30, 2027, or until each director's respective successor is elected and qualified.”
PharmaCyte Biotech, Inc. Form 8-K, filed April 2, 2026 · Read the filing
“On August 28, 2025, Jonathan Schechter resigned from his position as a member of the board of directors (the "Board") of TAO Synergies Inc. (the "Company") and as a member of all committees of the Board on which he serves.”
TAO Synergies Inc. Form 8-K, filed August 29, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at PharmaCyte Biotech, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at TAO Synergies Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.